Stocks News Update: Advanced Micro Devices, Inc. (NASDAQ:AMD), Zosano Pharma Corporation (NASDAQ:ZSAN)

1302
u.s stocks

Advanced Micro Devices, Inc. (NASDAQ:AMD)

The company announced its last quarter financial performance results on 01/31/2017. Advanced Micro Devices, Inc. (NASDAQ:AMD) belongs to Computer and Technology sector that declined -0.66% in value when last trading session closed at $13.49. The company has a market capitalization of $12.56 Billion. The company’s stock has a Return on Assets (ROA) of -15 percent, a Return on Equity (ROE) of 0 percent and Return on Investment (ROI) of -22.2 percent. The company reached its 52-Week high of $14.27 on Feb 7, 2017 and 52-Week low of $1.82 on Feb 16, 2016.

Earnings per share (ttm) for Advanced Micro Devices, Inc. (NASDAQ:AMD) according to Finviz Data is $-0.61.

The growth estimate for Advanced Micro Devices, Inc. (NASDAQ:AMD) for the current quarter is 66.7 percent. The projected growth estimate for the next quarter is 80 percent. The company’s stock has grown by -43.28 percent in the past 5 years. For the next 5 years, the company is expected to grow by -98.3 percent.

This company was Upgrade by Mizuho on 20-Dec-16  to Buy.

The 21 analysts offering 12-month price forecasts for Advanced Micro Devices Inc have a median target of 10.60, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a -21.42% decrease from the last price of 13.49.

Financial History:

Following Earnings result, share price were DOWN 20 times out of last 29 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 33% percent of times. It has met expectations  2  times and missed earnings  6  times.

The consensus recommendation for Advanced Micro Devices, Inc. (NASDAQ:AMD) is 2. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 2. In comparison, the consensus recommendation 60 days ago was at 2.38, and 90 days ago was at 2.38 respectively.

Future Expectations:

When the current quarter ends, Wall Street expects Advanced Micro Devices, Inc. to have earnings per share of $-0.04.

Revenue is expected to range from 965.92 Million to 986.8 Million with an average of 982.56 Million.

Company Profile:

Advanced Micro Devices, Inc. is a world-class company with the innovation, execution, and vision to grow our leadership position in the industry. Today’s world-class companies share three essential characteristics. First, they deliver innovative products and technologies that customers want. Second, they have established a proven track record of fast, efficient manufacturing execution. And third, they have a bold vision of where to take their business, and often their industry. Over the course of AMD’s three decades in business, silicon and software have become the steel and plastic of the worldwide digital economy. Technology companies have become global pacesetters, making technical advances at a prodigious rate always driving the industry to deliver more and more, faster and faster. AMD’s dedication to customer-centric innovation and competitive spirit is an unbroken thread running from our early days in the integrated circuit business, through an ever-broadening product portfolio.

Zosano Pharma Corporation (NASDAQ:ZSAN):

Zosano Pharma Corporation (NASDAQ:ZSAN) belongs to Medical sector closed its last session with a gain of 41.67 percent and closed its previous trading session at $1.7. According to Finviz reported data, the stock currently has Earnings per Share (EPS) (ttm) of $-2.38. The company has the Market capitalization of $29.33 Million. The company’s stock has a Return on Assets (ROA) of -82.8 percent, a Return on Equity (ROE) of -170.3 percent and Return on Investment (ROI) of -64.1 percent. The company reached its 52-Week high of $2.83 on Mar 1, 2016 and 52-Week low of $0.45 on Nov 3, 2016.

This company was Downgrade by Ladenburg Thalmann on 11-Aug-16 to Neutral.

The 1 analysts offering 12-month price forecasts for Zosano Pharma Corp have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +17.65% increase from the last price of 1.70.

Financial History:

Following Earnings result, share price were UP 4 times out of last 6 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 28% percent of times. It has met expectations  0 times and missed earnings  5  times.

The consensus recommendation for Zosano Pharma Corporation (NASDAQ:ZSAN) is 2. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 2. In comparison, the consensus recommendation 60 days ago was at 2, and 90 days ago was at 2 respectively.

Future Expectations:

When the current quarter ends, Wall Street expects Zosano Pharma Corporation to have earnings per share of $-0.45.

Company Profile:

Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s lead product candidates include Weekly ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan, for migraine. Zosano Pharma Corporation is headquartered in Fremont, California.